Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
24,52 USD | -2,15 % | +7,54 % | -24,51 % |
02/05 | CORCEPT THERAPEUTICS INCORPORATED : Truist Securities mantiene su recomendación de compra | ZM |
01/05 | Transcript : Corcept Therapeutics Incorporated, Q1 2024 Earnings Call, May 01, 2024 |
Resumen de negocios
Número de empleados: 352
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 402 | 100,0 % | 482 | 100,0 % | +20,04 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 402 | 100,0 % | 482 | 100,0 % | +20,04 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13/05/98 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 01/03/21 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/06/12 |
Hazel Hunt
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/11 |
Jerry Pan
IRC | Investor Relations Contact | - | 01/10/21 |
Amy E. Flood
IRO | Public Communications Contact | - | 12/07/21 |
William Guyer
PRN | Corporate Officer/Principal | 56 | 16/08/21 |
Monica Tellado
PRN | Corporate Officer/Principal | 51 | 01/11 |
Sean Maduck
PRN | Corporate Officer/Principal | 47 | 01/01/12 |
Gary Robb
SEC | Corporate Secretary | 61 | 01/09/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13/05/98 |
Gregg Alton
BRD | Director/Board Member | 58 | 12/03/20 |
George Baker
BRD | Director/Board Member | 81 | 01/01/99 |
James Wilson
CHM | Chairman | 80 | 01/01/99 |
David Mahoney
BRD | Director/Board Member | 69 | 01/07/04 |
Daniel Swisher
BRD | Director/Board Member | 61 | 18/06/15 |
Kimberly Park
BRD | Director/Board Member | 60 | 18/09/19 |
Gillian Cannon
BRD | Director/Board Member | 60 | 23/11/20 |
Joshua Murray
BRD | Director/Board Member | 40 | 09/06/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 135 312 088 | 92 262 472 ( 68,18 %) | 31 200 000 ( 23,06 %) | 68,18 % |
Información de la empresa
Corcept Therapeutics, Inc.
149 Commonwealth Drive
94025, Menlo Park
+650 327 3270
http://www.corcept.comRevisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-24,51 % | 2552,83 M | |
+26,08 % | 662 mil M | |
+21,85 % | 546 mil M | |
-4,77 % | 359 mil M | |
+16,97 % | 323 mil M | |
+5,69 % | 290 mil M | |
+13,68 % | 234 mil M | |
+3,65 % | 198 mil M | |
-11,12 % | 194 mil M | |
-3,40 % | 157 mil M |
- Bolsa de valores
- Acciones
- Acción CORT
- Empresa Corcept Therapeutics Incorporated